{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:44:32Z","timestamp":1786146272735,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministry of Education Science Research and Sport of the Slovak Republic","doi-asserted-by":"publisher","award":["VV-MVP-24-0135"],"award-info":[{"award-number":["VV-MVP-24-0135"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clbc.2026.06.014","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:56:55Z","timestamp":1782345415000},"page":"96-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-1059","authenticated-orcid":false,"given":"Michal","family":"Alexovi\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1n","family":"Sabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Bouchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clbc.2026.06.014_bib0001","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.06.014_bib0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-016-0732-2","article-title":"Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples","volume":"18","author":"Waldemarson","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.06.014_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.104955","article-title":"High-throughput proteomics of breast cancer subtypes: biological characterization and multiple candidate biomarker panels to patients\u2019 stratification","volume":"285","author":"Azevedo","year":"2023","journal-title":"J Proteomics"},{"issue":"2","key":"10.1016\/j.clbc.2026.06.014_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14789450.2018.1421071","article-title":"Protein biomarkers for subtyping breast cancer and implications for future research","volume":"15","author":"Mueller","year":"2018","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.clbc.2026.06.014_bib0006","article-title":"Proteomic analysis of breast cancer subtypes identifies stromal protein profiles that contribute to aggressive malignant behavior","author":"Burton","year":"2025","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.clbc.2026.06.014_bib0007","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.06.014_bib0008","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cge.13900","article-title":"Molecular intrinsic versus clinical subtyping in breast cancer: a comprehensive review","volume":"99","author":"Szymiczek","year":"2021","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2013.06.006","article-title":"Breast cancer classification by proteomic technologies: current state of knowledge","volume":"40","author":"Lam","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0010","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-019-09018-y","article-title":"Breast cancer quantitative proteome and proteogenomic landscape","volume":"10","author":"Johansson","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-024-01835-4","article-title":"Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection","volume":"26","author":"Raj-Kumar","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.06.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10259","article-title":"Proteomic maps of breast cancer subtypes","volume":"7","author":"Tyanova","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.clbc.2026.06.014_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.06.046","article-title":"Breast cancer classification based on proteotypes obtained by SWATH mass spectrometry","volume":"28","author":"Bouchal","year":"2019","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.clbc.2026.06.014_bib0014","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.ajpath.2017.07.003","article-title":"Next-generation proteomics and its application to clinical breast cancer research","volume":"187","author":"Mardamshina","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clbc.2026.06.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110776","article-title":"Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: a review","volume":"129","author":"Vellan","year":"2024","journal-title":"Clin Biochem"},{"issue":"15-16","key":"10.1016\/j.clbc.2026.06.014_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202200026","article-title":"Human peripheral blood mononuclear cells: a review of recent proteomic applications","volume":"22","author":"Alexovi\u010d","year":"2022","journal-title":"Proteomics"},{"key":"10.1016\/j.clbc.2026.06.014_bib0017","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cca.2020.04.015","article-title":"Recent advances in robotic protein sample preparation for clinical analysis and other biomedical applications","volume":"507","author":"Alexovi\u010d","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"7605","key":"10.1016\/j.clbc.2026.06.014_bib0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clbc.2026.06.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100220","article-title":"Proteogenomic analysis of breast cancer transcriptomic and proteomic data, using de novo transcript assembly: genome-wide identification of novel peptides and clinical implications","volume":"21","author":"Hari","year":"2022","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"10.1016\/j.clbc.2026.06.014_bib0020","first-page":"4006","article-title":"Proteomics and its applications in breast cancer","volume":"11","author":"Neagu","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clbc.2026.06.014_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104950","article-title":"Proteomics signatures of human breast cancer: a systematic review","volume":"216","author":"Garc\u00eda-Chico","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2026.06.014_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/mas.70014","article-title":"Data-independent acquisition mass spectrometry in tumor classification and cancer biomarker research","author":"Simonik","year":"2025","journal-title":"Mass Spectrom Rev"},{"issue":"1-3","key":"10.1016\/j.clbc.2026.06.014_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14789450.2023.2203390","article-title":"How valuable can proteogenomics be in clinical breast cancer research?","volume":"20","author":"Tran-Huynh","year":"2023","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"10.1016\/j.clbc.2026.06.014_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1878-0261.12850","article-title":"High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers","volume":"15","author":"Terkelsen","year":"2021","journal-title":"Mol Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.06.014_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.036","article-title":"Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy","volume":"183","author":"Krug","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.clbc.2026.06.014_bib0026","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1074\/mcp.M110.000398","article-title":"In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology","volume":"9","author":"Cha","year":"2010","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"10.1016\/j.clbc.2026.06.014_bib0027","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1021\/pr500676x","article-title":"Label-free proteomic analysis of breast cancer molecular subtypes","volume":"13","author":"Panis","year":"2014","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.clbc.2026.06.014_bib0028","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/annonc\/mds430","article-title":"Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse","volume":"24","author":"Cancello","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2026.06.014_bib0029","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jprot.2015.11.024","article-title":"Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers","volume":"132","author":"Pendharkar","year":"2016","journal-title":"J Proteomics"},{"issue":"20","key":"10.1016\/j.clbc.2026.06.014_bib0030","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1158\/0008-5472.CAN-18-1079","article-title":"Clinical proteomics of breast cancer reveals a novel layer of breast cancer classification","volume":"78","author":"Yanovich","year":"2018","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clbc.2026.06.014_bib0031","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cels.2016.02.001","article-title":"System-wide clinical proteomics of breast cancer reveals global remodeling of tissue homeostasis","volume":"2","author":"Pozniak","year":"2016","journal-title":"Cell Syst"},{"key":"10.1016\/j.clbc.2026.06.014_bib0032","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490(7418):61-70. doi:10.1038\/nature11412","DOI":"10.1038\/nature11412"},{"issue":"4","key":"10.1016\/j.clbc.2026.06.014_bib0033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jnci\/djr545","article-title":"A three-gene model to robustly identify breast cancer molecular subtypes","volume":"104","author":"Haibe-Kains","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2026.06.014_bib0034","article-title":"Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer","volume":"13","author":"Yang","year":"2023","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.clbc.2026.06.014_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70470","article-title":"The analysis of plasma proteomics for luminal a breast cancer","volume":"13","author":"Zhao","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0036","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1038\/s41598-026-39686-y","article-title":"Peripheral blood CD14\u2009+\u2009monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins","volume":"16","author":"Alexovi\u010d","year":"2026","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clbc.2026.06.014_bib0037","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1021\/acs.jproteome.1c00243","article-title":"Proteogenomic workflow reveals molecular phenotypes related to breast cancer mammographic appearance","volume":"20","author":"De Marchi","year":"2021","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.clbc.2026.06.014_bib0038","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/acs.jproteome.5b01091","article-title":"A description of the clinical proteomic tumor analysis consortium (CPTAC) common data analysis pipeline","volume":"15","author":"Rudnick","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clbc.2026.06.014_bib0039","article-title":"Proteogenomic integration reveals therapeutic targets in breast cancer xenografts","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41467-020-14381-2","article-title":"Microscaled proteogenomic methods for precision oncology","volume":"11","author":"Satpathy","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.014_bib0041","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s42003-023-04526-6","article-title":"Proteogenomics decodes the evolution of human ipsilateral breast cancer","volume":"6","author":"De Marchi","year":"2023","journal-title":"Commun Biol"},{"issue":"11","key":"10.1016\/j.clbc.2026.06.014_bib0042","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s12276-024-01332-w","article-title":"Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance","volume":"56","author":"Yoon","year":"2024","journal-title":"Exp Mol Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:31:08Z","timestamp":1786145468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1526820926000984"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.06.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}